Streetbeat News

SXTP

60 Degrees Pharmaceuticals, Inc.

Industry

Biotechnology

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

Open

1.07

Mkt cap

1.8M

Volume

93K

High

1.08

P/E Ratio

-0.62

52-wk high

18.36

Low

0.94

Div yield

N/A

52-wk low

0.70

Several stocks are experiencing significant pre-market movements. Acumen Pharmaceuticals, PainReform, Nova LifeStyle, argenx SE, AERWINS Technologies, BridgeBio Pharma, Nuvve Holding Corp., Cadrenal Therapeutics, Edgio, and Genprex are among the gainers. BYND Cannasoft Enterprises, ViewRay, Ebix, Frequency Therapeutics, Apellis Pharmaceuticals, Minerva Surgical, Baosheng Media Group Holdings, Western Acquisition Ventures Corp., Monopar Therapeutics, and 60 Degrees Pharmaceuticals are among the losers.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 12:45 pm

The article lists the stocks that gained and lost the most in Friday's mid-day session. Among the gainers, PainReform Ltd. (PRFX) shares climbed 103% after announcing pricing of a $2.7 million concurrent registered direct offering and private placement. Frequency Therapeutics, Inc. (FREQ) gained 41.7% after agreeing to merge with Korro Bio. Among the losers, Theseus Pharmaceuticals, Inc. (THRX) shares dipped 69.9% after discontinuing enrollment in Phase 1/2 study and terminating development of THE-630 for gastrointestinal stromal tumors. State Street Corporation (STT) fell 10.5% after reporting slightly worse-than-expected second-quarter revenues and an increase in total expenses.

Portfolio Pulse from Lisa Levin

July 14, 2023 | 4:54 pm

60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) recently went public, offering 1.42 million shares at $5.30 per share. On its first day of trading, the stock increased 24.80% from its opening price of $3.75 to its closing price of $4.68. The company has an insider lock-up period of 180 days, ending on January 08, 2024, during which major shareholders cannot sell their shares.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 9:30 pm

The article lists the stocks that gained and lost the most during Thursday's mid-day trading session. Progressive Corporation (NYSE:PGR) shares fell by 11.8% due to below-consensus Q2 results. Other notable losers include Viasat, Inc. (NASDAQ:VSAT) and Cryoport, Inc. (NASDAQ:CYRX). On the gainers' side, Synaptogenix, Inc. (NASDAQ:SNPX) and Jiuzi Holdings, Inc. (NASDAQ:JZXN) saw significant increases.

Portfolio Pulse from Lisa Levin

July 13, 2023 | 4:49 pm

U.S. stocks traded higher with the Nasdaq Composite gaining over 100 points. Delta Air Lines reported better-than-expected Q2 results with a 19% YoY adjusted operating revenue growth to $14.61 billion, beating the consensus of $14.46 billion. Shares of Jiuzi Holdings, Synaptogenix, and 60 Degrees Pharmaceuticals rose significantly. However, Viasat, Cryoport, and First Wave BioPharma shares dropped due to various reasons.

Portfolio Pulse from Lisa Levin

July 13, 2023 | 4:21 pm

Shares of 60 Degrees are experiencing increased trading activity due to post-IPO volatility.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 3:22 pm

US stocks traded higher with the Dow Jones gaining over 100 points. Producer prices for final demand in the U.S. rose 0.1% month-over-month in June. Jiuzi Holdings, Synaptogenix, and 60 Degrees Pharmaceuticals saw significant stock increases, while Viasat, Cryoport, and First Wave BioPharma experienced notable drops.

Portfolio Pulse from Lisa Levin

July 13, 2023 | 2:30 pm

Trading of 60 Degrees Pharmaceuticals shares has resumed.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:49 pm

Shares of 60 Degrees Pharmaceuticals were halted on a circuit breaker due to a significant increase in the stock price. The stock is now up by 56.8%.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:45 pm

Trading of 60 Degrees Pharmaceuticals shares has resumed after a circuit breaker halt.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 1:40 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.